SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001306923-21-000011
Filing Date
2021-02-16
Accepted
2021-02-16 16:14:13
Documents
2

Document Format Files

Seq Description Document Type Size
1 Aimmune_13G_A2.txt SC 13G/A 10324
2 Aimmune_13G_A2.pdf SC 13G/A 186701
  Complete submission text file 0001306923-21-000011.txt   269328
Mailing Address 470 UNIVERSITY AVE PALO ALTO CA 94301
Business Address 470 UNIVERSITY AVE PALO ALTO CA 94301 650-325-0772
Palo Alto Investors LP (Filed by) CIK: 0001306923 (see all company filings)

IRS No.: 770558164 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884
Business Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884 (650) 614-5220
Aimmune Therapeutics, Inc. (Subject) CIK: 0001631650 (see all company filings)

IRS No.: 452748244 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88972 | Film No.: 21638560
SIC: 2834 Pharmaceutical Preparations